ES2002302A6 - Una capsula de gelatina dura que contiene una composicion masticable - Google Patents

Una capsula de gelatina dura que contiene una composicion masticable

Info

Publication number
ES2002302A6
ES2002302A6 ES8601759A ES8601759A ES2002302A6 ES 2002302 A6 ES2002302 A6 ES 2002302A6 ES 8601759 A ES8601759 A ES 8601759A ES 8601759 A ES8601759 A ES 8601759A ES 2002302 A6 ES2002302 A6 ES 2002302A6
Authority
ES
Spain
Prior art keywords
active ingredient
composition
hard gelatin
chewable composition
gelatin capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601759A
Other languages
English (en)
Inventor
Brian Ellwood Jones
Paula Marion Knight
Mark Alexander Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Europe BV
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of ES2002302A6 publication Critical patent/ES2002302A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

UNA CAPSULA DE GELATINA DURA QUE CONTIENE UNA COMPOSICION MASTICABLE. LA CAPSULA CONTIENE: A) UNA COMPOSICION SEMI-SOLIDA QUE CONSTA DE UN INGREDIENTE PARA LA ABSORCION BUCAL O QUE TIENE ACTIVIDAD BUCAL, JUNTO CON UN VEHICULO NO TOXICO; Y B) UN AGENTE DE REALCE DE LA MASTICACION; SIENDO LIQUIDA DICHA COMPOSICION MASTICABLE A TEMPERATURAS INFERIORES A 100JC. OPCIONALMENTE, LA CAPSULA PUEDE CONTENER: A) EL CITADO INGREDIENTE ACTIVO; B) UN VEHICULO SEMI-SOLIDO NO TOXICO; Y C) EL AGENTE DE REALCE DE MASTICACION. MEDIANTE EL EMPLEO DE LA INVENCION SE PUEDE INCORPORAR HASTA UN 95% EN PESO DE INGREDIENTE ACTIVO EN LA COMPOSICION COMO INGREDIENTE ACTIVO SE PUEDE UTILIZAR CUALQUIER AGENTE CON ACTIVIDAD BUCAL DE ACCION LOCAL ASI COMO DROGAS CONDIACTIVAS, ANALGESICOS Y SEDANTES. LAS COMPOSICIONES UTILIZADAS PUEDEN SER RETENIDAS EN LA BOCA DURANTE LARGOS PERIODOS DE TIEMPO, PERMITIENDO QUE EL INGREDIENTE ACTIVO TENGA UN EFECTO MAXIMO.
ES8601759A 1985-09-11 1986-09-10 Una capsula de gelatina dura que contiene una composicion masticable Expired ES2002302A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858522453A GB8522453D0 (en) 1985-09-11 1985-09-11 Chewable capsules

Publications (1)

Publication Number Publication Date
ES2002302A6 true ES2002302A6 (es) 1988-08-01

Family

ID=10584991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601759A Expired ES2002302A6 (es) 1985-09-11 1986-09-10 Una capsula de gelatina dura que contiene una composicion masticable

Country Status (22)

Country Link
US (1) US4755389A (es)
EP (1) EP0215635B1 (es)
JP (1) JPH089535B2 (es)
KR (1) KR940002656B1 (es)
CN (1) CN1026463C (es)
AT (1) ATE69377T1 (es)
AU (1) AU590792B2 (es)
CA (1) CA1273295A (es)
DE (1) DE3682467D1 (es)
DK (1) DK174973B1 (es)
EG (1) EG17919A (es)
ES (1) ES2002302A6 (es)
GB (1) GB8522453D0 (es)
GR (1) GR862293B (es)
HU (1) HU198837B (es)
IE (1) IE59738B1 (es)
IL (1) IL79973A (es)
NZ (1) NZ217494A (es)
PH (1) PH22155A (es)
PT (1) PT83327B (es)
RU (1) RU2018305C1 (es)
ZA (1) ZA866849B (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2611501B1 (fr) * 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
GB8721455D0 (en) * 1987-09-11 1987-10-21 Lilly Industries Ltd Capsules
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5004601A (en) * 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5135752A (en) * 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
US5139790A (en) * 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
DE4217932A1 (de) * 1992-05-30 1993-12-02 Hans Werner Dr Mander Verwendung eines lichtdurchlässigen, elastischen Hohlkörpers als Hilfsmittel bei der Aushärtung von lichthärtenden Zahnfüllungsmassen
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9616672D0 (en) * 1996-08-08 1996-09-25 Scherer Ltd R P Pharmaceutical compositions
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
RU2363452C2 (ru) * 1996-12-24 2009-08-10 Федеральное Государственное Унитарное Предприятие Государственный Научно-Исследовательский Институт "Биоэффект" (Фгуп Гнии "Биоэффект") Состав для капсул
IN186245B (es) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
ES2293875T3 (es) 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US20030077229A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US6171615B1 (en) 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
RU2142688C1 (ru) * 1999-04-12 1999-12-20 Датиашвили Андриа Зауриевич Тара для хранения и транспортировки продуктов
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
AU3885201A (en) 1999-09-20 2001-04-24 Mastercare Diet and weight control gum and sucker
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
PL369425A1 (en) * 2001-06-11 2005-04-18 Warner-Lambert Company Llc Breath protection microcapsules
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
FR2881321B1 (fr) 2005-02-03 2008-12-26 Axiss France Sas Soc Par Actio Additif alimentaire pour ruminants a base d'eugenol et de cinnamaldehyde
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
CN101227892B (zh) 2005-04-08 2013-06-05 舌交付有限公司 口腔给药系统
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
JP2010513525A (ja) * 2006-12-22 2010-04-30 ノヴァデル ファーマ インコーポレイテッド 安定な抗嘔吐経口噴霧製剤および方法
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
WO2010137696A1 (ja) * 2009-05-29 2010-12-02 森下仁丹株式会社 口腔用薬剤組成物およびそれを封入した口腔用薬剤カプセル
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
US20120321703A1 (en) * 2011-06-16 2012-12-20 Daniel Kouri Capsule for oral pet medicine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
ES2910787T3 (es) 2016-05-12 2022-05-13 Univ Michigan Regents Inhibidores de ASH1L y métodos de tratamiento con los mismos
CN111542318A (zh) 2017-11-10 2020-08-14 密歇根大学董事会 Ash1l降解剂及用其进行治疗的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
NL7000180A (es) * 1969-01-10 1970-07-14
SU432703A3 (es) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US4196189A (en) * 1977-03-19 1980-04-01 Blendax-Werke R. Schneider Dental and oral hygiene preparations
AU526184B2 (en) * 1978-06-27 1982-12-23 Scherer, R.P. Pty. Ltd. Appetite suppressant compositions
US4238475A (en) * 1979-08-01 1980-12-09 Life Savers Inc. Chewing cum capable of releasing finely divided water-insoluble materials therefrom
US4292304A (en) * 1980-09-30 1981-09-29 Barels Ronald R Oil based dentifrice
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4532126A (en) * 1982-05-07 1985-07-30 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
JPS5967218A (ja) * 1982-10-07 1984-04-16 Grelan Pharmaceut Co Ltd 軟質な口腔製剤
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
WO1985000516A1 (en) * 1983-08-01 1985-02-14 R. P. Scherer Corporation Sustained release method and product
JPH0713012B2 (ja) * 1984-02-08 1995-02-15 ア−ル ピ− シ−ラ− コ−ポレ−シヨン アセトアミノフェン・ゼラチンカプセル
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HU198837B (en) 1989-12-28
IL79973A (en) 1990-06-10
IE59738B1 (en) 1994-03-23
GR862293B (en) 1987-01-02
DK433886D0 (da) 1986-09-10
AU590792B2 (en) 1989-11-16
EP0215635A2 (en) 1987-03-25
DK174973B1 (da) 2004-04-05
NZ217494A (en) 1989-03-29
EG17919A (en) 1991-06-30
JPS62116508A (ja) 1987-05-28
CN86106150A (zh) 1987-03-18
EP0215635A3 (en) 1988-01-13
ZA866849B (en) 1987-11-25
CA1273295A (en) 1990-08-28
US4755389A (en) 1988-07-05
PH22155A (en) 1988-06-01
PT83327A (en) 1986-10-01
DE3682467D1 (de) 1992-02-27
DK433886A (da) 1987-03-12
JPH089535B2 (ja) 1996-01-31
IL79973A0 (en) 1986-12-31
KR940002656B1 (ko) 1994-03-28
AU6245586A (en) 1987-03-12
PT83327B (pt) 1989-05-12
GB8522453D0 (en) 1985-10-16
KR870002839A (ko) 1987-04-13
ATE69377T1 (de) 1991-11-15
RU2018305C1 (ru) 1994-08-30
EP0215635B1 (en) 1992-01-15
IE862403L (en) 1987-03-11
CN1026463C (zh) 1994-11-09
HUT43951A (en) 1988-01-28

Similar Documents

Publication Publication Date Title
ES2002302A6 (es) Una capsula de gelatina dura que contiene una composicion masticable
ES2037866T3 (es) Una composicion desodorante en forma de gel.
ES2025057B3 (es) Agente para la higiene bucal.
ES2095043T3 (es) Composicion para preparados orales.
ES2010740A6 (es) Una composicion oral antibacteriana antiplacas y anticalculos, que contiene polifosfato.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
PH25319A (es)
MX9306051A (es) Composicion desodorante en forma de barra de gel estable.
CO5231147A1 (es) Composicion congelante
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
DE69804493D1 (de) Schweisshemmendes mittel mit dibenzylidensorbitol
ES2161214T3 (es) Composiciones farmaceuticas.
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
ES2129448T3 (es) Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas.
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
SE8600658D0 (sv) Novel composition of matter
GB1241914A (en) Biocidal and/or deodorising compositions
GB2021409A (en) Pharmaceutical composition
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
PT893121E (pt) Solucao medicinal liquida oral
ES2085332T3 (es) Gomas de mascar hipocaloricas y estimulantes de la salivacion, gomas de mascar provistas de un relleno central y gomas de mascar revestidas con un producto de confiteria y un metodo para su preparacion.
AR216892A1 (es) Composiciones fito-fungicidas que contienen como agentes activos a compuestos de 2-hidroxi 1,3,2-dio-xafosforinanos,utilizables para la lucha contra las enfermedades fungicas de las plantas
DK295082A (da) Komposition til topisk legemanvendelse
ES2029337T3 (es) Dentrifico con indicador de tiempo de cepillado.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-09-10

PC1A Transfer granted

Owner name: SHIONOGI EUROPE B.V.

FD1A Patent lapsed

Effective date: 20060911